Boule Diagnostics Q3 Sales Fall 24.4% to SEK 96M
Adjusted EBIT was SEK -4.5M. Instrument sales fell amid component shortages and weak demand; gross margin was 41.1% and order backlog SEK 76M.
Boule Diagnostics AB (publ) reported Q3 sales of SEK 96M, a 24.4% decline YoY, and adjusted EBIT of SEK -4.5M. Instrument sales dropped sharply amid component shortages and weak demand. Gross margin was 41.1%, while the order backlog stood at SEK 76M.